Table VII.
Autoinflammatory Disorders
Disease | Affected cells | Functional defects | Associated Features | Inheritance | Gene defects |
---|---|---|---|---|---|
Familial Mediterranean Fever | Mature granulocytes, cytokine-activated monocytes. | Decreased production of pyrin permits ASC-induced IL-1 processing and inflammation following subclinical serosal injury; macrophage apoptosis decreased. | Recurrent fever, serositis and inflammation responsive to colchicine. Predisoposes to vasculitis and inflammatory bowel disease. | AR | Mutations of MEFV |
TNF receptor-associated periodic syndrome (TRAPS) | PMNs, monocytes | Mutations of 55-kD TNF receptor leading to intracellular receptor retention or diminished soluble cytokine receptor available to bind TNF | Recurrent fever, serositis, rash, and ocular or joint inflammation | AD | Mutations of TNFRSF1A |
Hyper IgD syndrome | Mevalonate kinase deficiency affecting cholesterol synthesis; pathogenesis of disease unclear | Periodic fever and leukocytosis with high IgD levels | AR | Mutations of MVK | |
Muckle-Wells syndrome* | PMNs, monocytes | Defect in cryopyrin, involved in leukocyte apoptosis and NFkB signalling and IL-1 processing | Urticaria, SNHL, amyloidosis. Responsive to IL-1R/antagonist (Anakinra) | AD | Mutations of CIAS1 (also called PYPAF1 or NALP3) |
Familial Cold autoinflammatory syndrome* | PMNs, chondrocytes | same as above | Non-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposure. Responsive to IL-1R/antagonist (Anakinra) | AD | Mutations of CIAS1 |
Neonatal onset multisystem inflammatory disease (NOMID) or chronic infantile neurologic cutaneous and articular syndrome (CINCA)* | PMNs, chondrocytes | same as above | Neonatal onset rash, chronic meningitis, and arthropathy with fever and inflammation responsive to IL-1R antagonist (Anakinra) | AD | Mutations of CIAS1 |
Pyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA) syndrome | hematopoietic tissues, upregulated in activated T-cells | Disordered actin reorganization leading to compromised physiologic signaling during inflammatory response | Destructive arthritis, inflammatory skin rash, myositis | AD | Mutations of PSTPIP1 (also called C2BP1) |
Blau syndrome | Monocytes | Mutations in nucleotide binding site of CARD15, possibly disrupting interactions with lipopolysaccharides and NF-κB signaling | Uveitis, granulomatous synovitis, camptodactyly, rash and cranial neuropathies, 30% develop Crohn's disease | AD | Mutations of NOD2 (also called CARD15) |
Chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia (Majeed syndrome) | Neutrophils, bone marrow cells | Undefined | Chronic recurrent multifocal osteomyelitis, transfusion-dependent anemia, cutaneous inflammatory disorders | AR | Mutations of LPIN2 |
All three syndromes associated with similar CIAS1 mutations; disease phenotype in any individual appears to depend on modifying effects of other genes and environmental factors.
Abbreviations: As for Table 1; N, neutrophils; M, monocytes/macrophages; L, lymphocytes; NK, natural killer cells; AD, autosomal dominant inheritance. ASC, apoptosis-asocated speck-like protein with a caspase recruitment domain; CARD, caspase recruitment domain; CD2BP1, CD2 binding protein-1; PSTPIP1, Proline/serine/threonine phosphatase-interacting protein 1; SNHL - sensorineural hearing loss;CIAS1- cold-induced autoinflammatory syndrome 1